Evidence map›Paper›PMID 41940964›Full record

ReviewJournal of neural transmission (Vienna, Austria : 1996)2026

Genetic and environmental risk factors of Parkinsonism.

Petr Kanovsky, Katerina Mensikova, Pavel Cupr, Radek Vodicka, Kristyna Kolarikova, Tereza Strnadova, Sarah Elizabeth Victoria Cook, Dorota Sebelova-Konickova, Jana Klanova, Carlo Colosimo and 1 more

Abstract readReview
In one paragraph

Review in Journal of neural transmission (Vienna, Austria : 1996), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Petr KanovskyDepartment of Neurology, University Hospital Olomouc, Olomouc, Czech Republic. petr.kanovsky@fnol.cz.ORCID http://orcid.org/0000-0002-9009-3241
Katerina MensikovaDepartment of Neurology, University Hospital Olomouc, Olomouc, Czech Republic.ORCID http://orcid.org/0000-0003-4834-3160
Pavel CuprRECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic.ORCID http://orcid.org/0000-0002-3848-7091
Radek VodickaDepartment of Clinical Genetics, University Hospital Olomouc, Olomouc, Czech Republic.ORCID http://orcid.org/0000-0002-7546-5676
Kristyna KolarikovaDepartment of Clinical Genetics, University Hospital Olomouc, Olomouc, Czech Republic.
Tereza StrnadovaDepartment of Neurology, University Hospital Olomouc, Olomouc, Czech Republic.ORCID http://orcid.org/0009-0008-5784-0816
Sarah Elizabeth Victoria CookDepartment of Neurology, University Hospital Olomouc, Olomouc, Czech Republic.ORCID http://orcid.org/0000-0002-4389-947X
Dorota Sebelova-KonickovaDepartment of Neurology, University Hospital Olomouc, Olomouc, Czech Republic.ORCID http://orcid.org/0000-0003-4446-0060
Jana KlanovaRECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic.ORCID http://orcid.org/0000-0002-8818-5307
Carlo ColosimoDepartment of Neurology, University Hospital Santa Maria, Terni, Italy.ORCID http://orcid.org/0000-0002-2216-3973
Raymond RosalesDepartment of Neurology and Psychiatry, University of Santo Tomás, Manila, Philippines.ORCID http://orcid.org/0000-0001-6387-1389

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinsonian disorders comprise a broad spectrum of neurodegenerative diseases with a wide variety of pathogenetic processes. These processes lead to the formation of pathological proteins, resulting in the brain diseases called synucleinopathies, tauopathies or TDP-43 proteinopathies. There is currently growing support for the hypothesis that genetic variants explain a significant fraction of the etiology of apparently sporadic parkinsonian disorders. Genetic risk factors can be stratified according to the metabolic or structural processes that can lead to cellular disturbance; these processes involve protein aggregation, protein and membrane trafficking, stabilization of the neurite structure, prion-like transmission of pathological proteins, ubiquitin-proteasome system balance, mitophagy, lysosome autophagy, synaptic functions, and dopamine transmission. Regarding the environmental risk factors, there are several substances that have been supposed of being a risk for the development of neurodegenerative proteinopathy and Parkinsonism, mainly the agents used in agriculture and the textile industry. The most important and most frequently studied are pesticides and trichlorethylene. Beside the globally ubiquitous substances which are supposedly neurotoxic and exposure to which can cause manifestations of Parkinsonism, there are more geographically (regionally) specific substances, which cause (or quite recently caused) the manifestation of endemically present Parkinsonism. Among ten types of endemic Parkinsonism, three of them are thought to have an environmental cause: Western Pacific Parkinsonism, Caribbean Parkinsonism, and North France cluster of atypical Parkinsonism.

Indexed as

Gene-Environment InteractionGenetic Predisposition to DiseaseParkinsonian DisordersAnimalsHumansRisk FactorsParkinson´ disease - alpha-synuclein - genetics - environment - risk factors

Identifiers

PMID41940964
PMCPMC13428785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.